ÂÜÀòÂÒÂ×

Rochelle Duong has a diverse work experience spanning over two decades. Rochelle currently holds the position of Director, Clinical Operations & Client Solutions at Aetonix, a role they have been in since December 2022. Before joining Aetonix, Rochelle served as the Director, Clinical Programs and Pathways at Trudell Medical Limited from June 2021 to December 2022.

Rochelle's previous experience includes managerial roles at Ontario Health (Central Region), where they worked as the Manager, Clinical Programs, Wound Care from February 2015 to June 2021. Prior to that, Rochelle was the Director, Clinical Operations at Cardinal Health from September 2012 to October 2014.

Before transitioning into management roles, Rochelle gained valuable experience in the healthcare industry in various capacities. Rochelle worked as the Marketing Manager for Bard Medical Canada from September 2010 to September 2012 and as the National Product Manager for Patient Handling at Stryker Medical from April 2008 to September 2010. In addition, Rochelle served as the National Sales Trainer at KCI Medical from January 2004 to April 2008.

Rochelle's clinical experience includes roles as a Registered Nurse in surgical oncology at Sunnybrook Health Sciences Centre and as a Registered Nurse in inflammatory bowel disease (IBD) at Mount Sinai Hospital, both from 2001 to 2005.

Furthermore, Rochelle gained valuable experience in the field of clinical research as a Clinical Research Nurse/Medical Writer at Biovail from 2001 to 2003.

Overall, Rochelle Duong's work experience showcases their extensive knowledge and expertise in clinical operations, program management, and patient care across various healthcare organizations.

Rochelle Duong, RN, BScN, MHA pursued their Bachelor of Science in Nursing (BScN) degree from Ryerson University between 1997 and 2001. Rochelle then recently acquired a Master's degree in Health/Health Care Administration/Management from the Ted Rogers School of Management at Toronto Metropolitan University, completing their studies between 2019 and 2021.